Orencia

J&J, BMS arthritis drugs lowered death risk among COVID patients in federal study
Fierce Pharma
Thu, 06/2/22 - 07:29 pm
JNJ
Bristol Myers Squibb
COVID-19
rheumatoid arthritis
clinical trials
Orencia
Remicade
Bristol Myers drug wins first U.S. approval for Graft versus Host Disease prevention
Reuters
Wed, 12/15/21 - 11:54 pm
Bristol Myers Squibb
Orencia
FDA
graft vs host disease
Bristol-Myers Squibb gets FDA breakthrough therapy status for Orencia to prevent GvHD
Pharmaceutical Business Review
Thu, 12/5/19 - 10:06 am
Bristol-Myers Squibb
Orencia
graft vs host disease
FDA
breakthrough status
Momenta's (MNTA) Biosimilar Study Fails, Q3 Loss Narrows
Yahoo/Zacks.com
Fri, 11/3/17 - 09:07 am
Momenta
earnings
biosimilars
M834
Orencia
Prescribed Reading: I/O is the only game in town
BioPharma Dive
Sat, 07/8/17 - 10:02 am
immuno-oncology
Celgene
BeiGene
Endo International
Opana ER
Novartis
Orkambi
Vertex Pharmaceuticals
Merck
Bristol-Myers Squibb
Roche
Opdivo
Keytruda
Orencia
Apples To Apples: Organovo Vs. Repligen
Seeking Alpha
Mon, 01/20/14 - 02:46 pm
Organovo
Repligen
bio-ink
Orencia
3 Important Catalysts That Fueled Repligen in 2013
Motley Fool
Thu, 12/12/13 - 08:42 am
Repligen
Orencia
Bristol-Myers Squibb
monoclonal antibodies
What the End of Bristol-Myers Squibb Royalties Means for Repligen
Motley Fool
Fri, 11/15/13 - 11:51 am
Repligen
Bristol-Myers Squibb
Orencia
Top 10 rheumatoid arthritis drugs 2013
Fierce Pharma
Wed, 09/18/13 - 10:27 am
rheumatoid arthritis
Humira
AbbVie
Enbrel
Amgen
Remicade
Janssen
Celebrex
Pfizer
Bristol-Myers Squibb
Orencia
Cimza
UCB
Simponi
JNJ
Arthrotec
Vimovo
AstraZeneca
Kineret
Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia(R) SC (abatacept) in China
Yahoo
Fri, 06/14/13 - 10:27 am
Bristol-Myers Squibb
China
Simcere
Orencia
rheumatoid arthritis
Can Bristol-Myers Squibb Compete In Immuno-Oncology?
Seeking Alpha
Mon, 04/8/13 - 11:03 am
immuno-oncology
cancer
Bristol-Myers Squibb
AbbVie
Ariad Pharmaceuticals
JNJ
Eli Lilly
Novartis
Pfizer
Medivation
Erbitux
Yervoy
Sprycel
Orencia
This Blockbuster Drug Gets a Green Light
Motley Fool
Sat, 12/8/12 - 11:31 am
Bristol-Myers Squibb
arthritis
Orencia
Bristol-Myers Squibb Zeroes In On A Blockbuster Cancer Drug
Seeking Alpha
Tue, 09/27/11 - 07:31 pm
Bristol-Myers Squibb
Orencia
MDX-1106
BMS-936558
Ono Pharmaceutical
U.S. Food and Drug Administration Approves Subcutaneous Formulation of ORENCIA® (abatacept), a Proven Non-Anti-TNF Biologic for Adults with Moderate to Severe Rheumatoid Arthritis
Yahoo/BusinessWire
Sat, 07/30/11 - 10:40 am
Orencia
rheumatoid arthritis
Bristol-Myers Squibb
Bristol-Myers Arthritis Drug Fails to Win Backing of U.K. Agency
Bloomberg
Wed, 03/30/11 - 09:49 am
UK
arthritis
Bristol-Myers Squibb
Orencia
Bristol-Myers Squibb: Outstanding Pipeline Makes It Most Attractive Among Large Pharmaceuticals
Seeking Alpha
Fri, 02/25/11 - 12:06 am
pipelines
Bristol-Myers Squibb
Reyataz
HIV
Baraclude
Orencia
rheumatoid arthritis
Sprycel
chronic myeloid leukemia
Onglyza
diabetes
hepatitis B
Bristol-Myers' Orencia gets expanded use in Europe
Yahoo/AP
Wed, 07/7/10 - 12:15 pm
Bristol-Myers Squibb
Orencia
Europe
rheumatoid arthritis
Will new label help Bristol's Orencia?
Fierce Pharma
Thu, 08/27/09 - 04:24 pm
Bristol-Myers Squibb
Orencia
Bristol-Myers' Orencia: Small Change, Big Impact?
Motley Fool
Thu, 08/27/09 - 07:40 am
Orencia
Bristol-Myers Squibb
Bristol-Myers says FDA broadens label for Orencia
Yahoo/AP
Wed, 08/26/09 - 10:19 am
FDA
Bristol-Myers Squibb
Orencia
rheumatoid arthritis